2016 annual financial data

Viridian Therapeutics 2016 Net margin

Direct answer

Net margin was -379.8%.

Operating income was -12.51M USD and net income was -12.67M USD.
Operating cash flow was -7.23M USD.

Get free Viridian Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
3.34M USD
Operating income
-12.51M USD
Net income
-12.67M USD
Operating cash flow
-7.23M USD